Persistent URL of this record https://hdl.handle.net/1887/121503
In Collections
This item can be found in the following collections:
![Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1 alpha and anti-interleukin-1 beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1 alpha and anti-interleukin-1 beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
- All authors
- Kloppenburg, M.; Peterfy, C.; Haugen, I.K.; Kroon, F.; Chen, S.; Wang, L.; Liu, W.; Levy, G.; Fleischmann, R.M.; Berenbaum, F.; Heijde, D. van der; Bansal, P.; Wittoek, R.; Feng, S.; Fang, Y.N.; Saltarelli, M.; Medema, J.K.; Levesque, M.C.
- Date
- 2019-03-01
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 78
- Issue
- 3
- Pages
- 413 - 420